The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4'-((3aR,6aS)-hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-6',7'-dihydro-5'H-spiro[cyclopentane-1,8'-quinazolin]-2'-amine ID: ALA1081682
PubChem CID: 46881969
Max Phase: Preclinical
Molecular Formula: C18H27N5
Molecular Weight: 313.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc(N2C[C@H]3CNC[C@H]3C2)c2c(n1)C1(CCCC1)CCC2
Standard InChI: InChI=1S/C18H27N5/c19-17-21-15-14(4-3-7-18(15)5-1-2-6-18)16(22-17)23-10-12-8-20-9-13(12)11-23/h12-13,20H,1-11H2,(H2,19,21,22)/t12-,13+
Standard InChI Key: XXLYCVCLLJFPNH-BETUJISGSA-N
Molfile:
RDKit 2D
25 29 0 0 0 0 0 0 0 0999 V2000
13.2530 -15.9081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0363 -15.1081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2085 -15.0669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9135 -15.8415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5591 -16.3613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9646 -14.6732 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.3950 -15.4994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3918 -14.6689 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6762 -14.2601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6734 -13.4351 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1104 -15.9104 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6756 -15.9152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9638 -15.5010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2482 -16.7310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9600 -17.1451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6768 -16.7364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2009 -16.7327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8658 -15.5753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4192 -16.1871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0129 -16.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5652 -17.5068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3131 -17.1690 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2228 -16.3534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5958 -17.6083 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
17.8250 -15.4667 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
6 13 2 0
12 7 2 0
2 3 1 0
12 16 1 0
13 1 1 0
1 14 1 0
14 15 1 0
15 16 1 0
11 17 1 0
7 8 1 0
3 4 1 0
17 20 1 0
19 18 1 0
18 11 1 0
19 20 1 0
8 9 2 0
9 6 1 0
4 5 1 0
9 10 1 0
5 1 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 19 1 0
7 11 1 0
20 24 1 6
12 13 1 0
19 25 1 6
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 313.45Molecular Weight (Monoisotopic): 313.2266AlogP: 1.86#Rotatable Bonds: 1Polar Surface Area: 67.07Molecular Species: BASEHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 11.12CX LogP: 2.64CX LogD: -0.65Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.83Np Likeness Score: -0.14
References 1. Koenig JR, Liu H, Drizin I, Witte DG, Carr TL, Manelli AM, Milicic I, Strakhova MI, Miller TR, Esbenshade TA, Brioni JD, Cowart M.. (2010) Rigidified 2-aminopyrimidines as histamine H4 receptor antagonists: effects of substitution about the rigidifying ring., 20 (6): [PMID:20171098 ] [10.1016/j.bmcl.2010.01.131 ] 2. Koenig JR, Liu H, Drizin I, Witte DG, Carr TL, Manelli AM, Milicic I, Strakhova MI, Miller TR, Esbenshade TA, Brioni JD, Cowart M.. (2010) Rigidified 2-aminopyrimidines as histamine H4 receptor antagonists: effects of substitution about the rigidifying ring., 20 (6): [PMID:20171098 ] [10.1016/j.bmcl.2010.01.131 ]